![]() |
|
|
|
RELIEF FROM
HOT FLASHES: It
is well established that estrogen replacement provides relief from hot ashes.
The questions investigators are asking now relate to the most effective form of
estrogen replacement. For example, Simon and colleagues recently compared
estrogen-androgen therapy with estrogen-only therapy for efficacy in relieving
vasomotor symptoms. In their trial, 93 patients were randomized to receive 1 of
5 daily regimens for 3 months: oral CEE (0.625 mg or 1.25 mg), oral CEE combined
with methyltestosterone (0.625 mg and 1.25 mg or 1.25 mg and 2.5 mg), or
placebo. These investigators found that the extent of relief with the lower-dose
estrogen-androgen treatment was similar to that achieved with the higher-dose
estrogen-only treatment. ESTROGEN
METHODS:
Currently,
estrogen replacement is delivered orally or transdermally; both means have
disadvantages, including variable bioavailability, intestinal and hepatic
first-pass effects (oral), and Of note are recent findings that women who have no vasomotor symptoms when they begin HRT do not develop such symptoms when treatment is first instituted and then abruptly stopped after 3 months. This may be useful information for a clinician to provide a patient who is undecided about whether to begin HRT when she is not experiencing vasomotor symptoms. WHAT ESTROGEN IS NOT: Estrogen is not one hormone, it is the name of a group of hormones. There are three principle forms of estrogen found in the human body estrone, estradiol and estriol, also known as E1, E2 and E3 respectively. There is also a group of compounds called phytoestrogens, generally found in food, which can have "estrogen like" effects in the body. Estradiol (E2) is the primary estrogen produced by the ovaries. Estrone (E1) is formed from estradiol. It is a weak estrogen and is the most abundant estrogen found in the body after menopause. Estriol (E3) is produced in large amounts during pregnancy and is a breakdown product of estradiol. Estriol is also a weak estrogen and may have anti-cancer effects. Before menopause estradiol is the predominant estrogen. After menopause estradiol levels drop more than estrone so that now estrone is the predominant estrogen. For the past 50 years, conjugated equine estrogen, brand name Premarin® has been the most commonly prescribed estrogen supplement in the U.S. Conjugated estrogens are derived from pregnant mare's urine. They must be converted by the body into active estrogens. Premarin® is the most studied estrogen supplement. It is also the most widely prescribed hormone in the world. If you are taking a hormone, it is probably Premarin®. Estradiol (E2) is now widely prescribed in the form of skin patches, tablets and creams and is gaining on premarin in popularity. A combination of E1,E2 and E3 called Triple Estrogen or Tri-Est,has been available for many years. It's proponents claim it is the most natural way to take estrogen. Triple estrogen is difficult to get. It is generally available only by mail order THE MOST EFFECTIVE HERB: One of the most effective herbal products available today, Imperial Gold Maca™ has been making a strong presence in the United States and many foreign countries. Sold usually in health food stores or by women who have used the product and now distribute it, Imperial Gold Maca™ seems to be coming the natural choice of most women. With a reputation of no known side effects, which is highly desirable, Imperial Gold Maca™ has been known to also increase energy, stamina, alertness and fertility enhancement. User's who have tried drug products rave of the natural benefits. Gaining popularity slowly, it seems to be a word of mouth campaign conducted by the 1000's of women who are currently advocates of this herb that seems to promote estrogen and progesterone naturally. The best source of progesterone and estrogen is your own body. For the most part, nothing could be more natural, and carry no risk of known side effects. SEE MACA |
|
|
|
So which is natural? Is natural better? If so why? |
| PLANT BASED | |||||
| Drug Name or Herb | Route | Years |
FDA Approved
or Herbal Requiring No FDA Approval |
Strength | Cost/Day* |
| Alora® | Transdermal | 1 | Menopausal Syndrome |
0.05 mg 0.075 mg 0.1 mg |
0.72 0.72 0.72 |
| Cenestin® | Oral | 1 | Menopausal Syndrome |
0.625 mg 0.9 mg |
0.37 0.37 |
| Climara® | Transdermal | 1 | Menopausal Syndrome |
0.05 mg 0.75 mg 0.1 mg |
0.72 0.72 0.72 |
| Estrace® |
Oral Vaginal |
20 10 |
Menopausal
Syndrome Osteoporosis Vaginal Atrophy |
0.5 mg 1.0 mg 2.0 mg 0.1% cream |
0.31 0.38 0.56 1.61 |
| Estroderm® | Transdermal | 10 |
Menopausal
Syndrome Osteoporosis |
0.05 mg 0.1 mg |
0.72 0.80 |
| Estratab® | Oral | 20 |
Menopausal Syndrome Osteoporosis |
0.3 mg 0.625 mg 1.25 mg 2.5 mg |
0.32 0.32 0.32 0.32 |
| Estring® | Vaginal Ring | 1 | Vaginal Atrophy | 5-10 mg |
|
| FemPatch® | Transdermal | 1 | Menopausal Syndrome |
0.05 mg 0.1 mg |
0.72 0.72 |
|
Imperial
Gold Maca™
|
Oral | 100+ |
Menopausal
Syndrome Osteoporosis Vaginal Atrophy Fatigue Fertility Aphrodisiac Mental Clarity Libido Improvement |
600
mg Suggested 6 Daily For First 2 Week 's For Maximum Results. |
0.20 |
| Menest® | Oral | 20 | Menopausal Syndrome |
0.3 mg 0.625 mg 1.25 mg 2.5 mg |
0.32 0.32 0.32 0.32 |
| Ogen® | Oral | 40 |
Menopausal Syndrome Osteoporosis |
0.625 mg 1.25 |
0.58 0.77 |
| Ortho-est® | Oral | 2 | Menopausal Syndrome |
0.625 mg 1.25 mg |
0.58 0.77 |
| Vivelle® | Transdermal | 1 | Menopausal Syndrome |
0.037 mg 0.05 0.75 0.1 |
0.72 0.72 0.72 0.72 |
| ANIMAL BASED | |||||
| Drug Name | Route | Years | FDA Approved for | Strength | Cost/Day* |
| Premarin® | Oral | 50 |
Menopausal Syndrome Osteoporosis |
0.3 mg 0.625 mg 0.9 mg 1.25 mg 2.5 mg |
0.37 0.37 0.37 0.37 0.37 |
| ESTROGEN/PROGESTERONE COMBINATIONS | |||||
| Drug Name | Route | Years | FDA Approved for | Strength | Cost/day* |
| CombiPatch® | Transdermal | 1 | Menopausal Syndrome |
0.05 mg estradiol 0.14 mg norethindrone |
0.72 |
| femhrt® | Oral | 1 |
Menopausal Syndrome Osteoporosis |
5 mcg ethinyl estradiol 1 mg norethindrone continous |
0.73 |
| Ortho-Prefest® | Oral | 1 |
Menopausal Syndrome Osteoporosis |
1 mg estradiol 0.09 mg norgestimate sequential |
0.73 |
| Prempro® | Oral | 5 |
Menopausal Syndrome Osteoporosis |
0.625 mg premarin 2.5 mg cycrin continous |
0.73 |
| Premphase® | Oral | 5 |
Menopausal Syndrome Osteoporosis |
0.625 mg premarin 5 mg cycrin sequential |
0.73 |
| ESTROGEN - ANDROGEN COMBINATIONS | |||||
| Drug Name | Route | Years | FDA Approved for | Strength | Cost/Day* |
| Estratest® | Oral | 5 |
Menopausal Syndrome Osteoporosis |
1.25/2.5 mg | 0.90 |
| Estratest HS® | Oral | 5 |
Menopausal Syndrome Osteoporosis |
0.625/1.25 mg | 0.74 |